Could a gut-friendly supplement help manage type 1 diabetes?
NCT ID NCT03999853
First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This early-phase study tested whether a special butyrate tablet (BKR-017) could help people with type 1 diabetes better control their blood sugar and lower fats in the blood. Six adults took the tablets for 28 days while researchers measured changes in insulin sensitivity and triglyceride levels. The goal was to see if this supplement could be a helpful addition to standard diabetes care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.